Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 reduced dermatology visits by 30.4%, with more male patients and increased cases of psoriasis, bullous diseases, and melanoma.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

A man experienced hair loss after getting COVID-19, which improved with treatment and might have been triggered by stress related to the illness.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

An 80-year-old man with COVID-19 also had constrictive pericarditis, possibly due to an autoimmune or immunoglobulin related disease, and improved after surgery.

Insulin resistance linked to obesity may increase COVID-19 severity.

Anabolic steroid users may face higher risk of severe COVID-19.

The pandemic changed how often certain skin conditions were diagnosed.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

People who had severe COVID-19 are more likely to experience hair loss.

The treatment might help COVID-19 related hair loss, but more research is needed.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

The AndroCoV Clinical Scoring is an accurate, easy, and free way to diagnose COVID-19 without a lab test.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Public interest in skin issues changed during COVID-19, with more focus on dry skin, hair problems, and hand eczema.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

QR678 Neo® hair growth treatment is effective for hair loss caused by Covid-19.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

COVID-19 changed dermatology by increasing telemedicine and highlighting healthcare disparities.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

Extra virgin olive oil may boost the immune system and help fight infections like COVID-19.